Efficacy and Safety of the Tadarafil Monotherapy or Coadministration of Tadarafil with Dutasteride in Men with Benign Prostatic Hyperplasia: A Phase III Randomized Open-Label Study
Phase of Trial: Phase III
Latest Information Update: 19 Oct 2016
At a glance
- Drugs Dutasteride (Primary) ; Tadalafil (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Acronyms TMCTD
- 15 Oct 2016 Status changed from recruiting to discontinued.
- 18 Nov 2015 Status changed from not yet recruiting to recruiting, according to University Hospital Medical Information Network - Japan.
- 05 Nov 2015 New trial record